We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+31.12%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$3.04B
AUM Growth
+$2.08B
Cap. Flow
+$1.67B
Cap. Flow %
55.04%
Top 10 Hldgs %
26.16%
Holding
518
New
283
Increased
39
Reduced
50
Closed
120

Top Buys

Rank Stock Value
1
AAL icon
American Airlines Group
AAL
+$99.6M
2
TMUS icon
T-Mobile US
TMUS
+$89.9M
3
PCG icon
PG&E
PCG
+$79.7M
4
OKE icon
Oneok
OKE
+$68.2M
5
TME icon
Tencent Music
TME
+$59.9M

Sector Composition

Rank Sector Weight
1 Communication Services 9.75%
2 Healthcare 9.36%
3 Industrials 8.38%
4 Technology 7.16%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
351
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
$264K 0.01%
+2,700
New +$238K
APRE icon
352
Aprea Therapeutics
APRE
$7.68M
$235K 0.01%
+303
New +$199K
RETA
353
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$234K 0.01%
1,500
-1,200
-44% -$182K
DLTR icon
354
PUT
Dollar Tree
DLTR
$24.4B
$232K 0.01%
+2,500
New +$209K
DIS icon
355
Walt Disney
DIS
$167B
$231K 0.01%
+2,070
New +$229K
CHRW icon
356
CALL
C.H. Robinson
CHRW
$17.4B
$229K 0.01%
+2,900
New +$219K
NETI
357
DELISTED
Eneti Inc.
NETI
$225K 0.01%
+14,695
New +$288K
CSCO icon
358
CALL
Cisco
CSCO
$457B
$210K 0.01%
4,500
-45,500
-91% -$2M
IMMU
359
PUT
DELISTED
Immunomedics Inc
IMMU
$202K 0.01%
+5,700
New +$167K
AFL icon
360
CALL
Aflac
AFL
$64.9B
$198K 0.01%
+5,500
New +$199K
REGN icon
361
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
$187K 0.01%
300
-3,000
-91% -$1.7M
HSY icon
362
PUT
Hershey
HSY
$35.2B
$181K 0.01%
+1,400
New +$188K
PLUG icon
363
CALL
Plug Power
PLUG
$2.87B
$168K 0.01%
+20,500
New +$96K
DFS
364
PUT
DELISTED
Discover Financial Services
DFS
$165K 0.01%
+3,300
New +$145K
PLUG icon
365
PUT
Plug Power
PLUG
$2.87B
$165K 0.01%
+20,100
New +$94.1K
WBA
366
CALL
DELISTED
Walgreens Boots Alliance
WBA
$157K 0.01%
+3,700
New +$157K
HSY icon
367
CALL
Hershey
HSY
$35.2B
$156K 0.01%
+1,200
New +$161K
PFE icon
368
CALL
Pfizer
PFE
$143B
$150K ﹤0.01%
+4,848
New +$165K
TEVA icon
369
PUT
Teva Pharmaceuticals
TEVA
$40.8B
$147K ﹤0.01%
11,900
-579,400
-98% -$6.55M
OXY icon
370
CALL
Occidental Petroleum
OXY
$56.8B
$146K ﹤0.01%
+8,000
New +$126K
WDC icon
371
CALL
Western Digital
WDC
$188B
$146K ﹤0.01%
4,366
-14,156
-76% -$459K
CCL icon
372
Carnival Corporation Ltd
CCL
$38.1B
$138K ﹤0.01%
+8,400
New +$126K
NVCR icon
373
CALL
NovoCure
NVCR
$1.73B
$136K ﹤0.01%
+2,300
New +$151K
DVN icon
374
Devon Energy
DVN
$52.1B
$125K ﹤0.01%
+11,000
New +$125K
VALE icon
375
Vale
VALE
$64.1B
$123K ﹤0.01%
+11,900
New +$109K

Similar funds

CAAS Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, CAAS Capital Management held 518 positions worth $3.04B, up 218% from $958M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

CAAS Capital Management deployed $1.67B of net new capital in Q2 2020, opening 283 new positions and adding to 39 existing holdings. Its largest new stake was American Airlines Group: 8,214,200 shares worth $107M.

By sector, the portfolio is most concentrated in Communication Services at 9.7% of assets, up from 4.3% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was ServiceNow, an estimated $5.65M trimmed.

  • CAAS Capital Management's largest Q2 2020 buy was American Airlines Group: 8,214,200 shares worth $107M.
  • CAAS Capital Management added most to US Steel in Q2 2020, an estimated $46.9M increase.
  • CAAS Capital Management's biggest Q2 2020 reduction was ServiceNow, cutting an estimated $5.65M.
  • CAAS Capital Management fully exited RTX Corp in Q2 2020, selling an estimated $45.5M.
  • CAAS Capital Management's ten largest holdings make up 26% of its $3.04B portfolio in Q2 2020.
  • CAAS Capital Management opened 283 new positions and closed 120 in Q2 2020.
  • CAAS Capital Management's portfolio value rose 218% quarter-over-quarter to $3.04B.

Based on CAAS Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.